Neural crest cell signaling pathways critical to cranial bone development and pathology

Experimental Cell Research

Volumn 325, Issue 2, 2014, Pages 138-147

  Mishina, Yuji ^a   Snider, Taylor Nicholas ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

BMP; Craniofacial anomaly; Development; Hedgehog; Neural crest; Wnt

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR; MUTANT PROTEIN; SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

BONE DEVELOPMENT; CELL CULTURE; CRANIAL SUTURE; CRANIOFACIAL DEVELOPMENT; CRANIOFACIAL MALFORMATION; CRANIOFACIAL SYNOSTOSIS; CROUZON SYNDROME; DIGEORGE SYNDROME; GENETIC ASSOCIATION; HUMAN; MANDIBULOFACIAL DYSOSTOSIS; MULTIPOTENT STEM CELL; NEURAL CREST; NEURAL CREST CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SKULL; TRANSGENIC MOUSE; VELOCARDIOFACIAL SYNDROME; WNT SIGNALING PATHWAY;

ERINACEIDAE;

BMP; CRANIOFACIAL ANOMALY; DEVELOPMENT; HEDGEHOG; NEURAL CREST; WNT;

ANIMALS; BONE DEVELOPMENT; EMBRYONIC DEVELOPMENT; HUMANS; NEURAL CREST; SIGNAL TRANSDUCTION; SKULL;

EID: 84902775892     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.01.019     Document Type: Review

References (139)

1. Achilleos A., Trainor P.A. Neural crest stem cells: discovery, properties and potential for therapy. Cell Res. 2012, 22:288-304.
2. Trainor P.A. Craniofacial birth defects: the role of neural crest cells in the etiology and pathogenesis of Treacher Collins syndrome and the potential for prevention. Am. J. Med. Genet. A 2010, 152A:2984-2994.
3. Fernandez L., Nevado J., Santos F., Heine-Suner D., Martinez-Glez V., Garcia-Minaur S., Palomo R., Delicado A., Pajares I.L., Palomares M., Garcia-Guereta L., Valverde E., Hawkins F., Lapunzina P. A deletion and a duplication in distal 22q11.2 deletion syndrome region. Clinical implications and review. BMC Med. Genet. 2009, 10:48.
4. Bush J.O., Jiang R. Palatogenesis: morphogenetic and molecular mechanisms of secondary palate development. Development 2012, 139:231-243.
5. Liu K.J. Future directions: molecular approaches provide insights into palatal clefting and repair. Front. Oral Biol. 2012, 16:147-154.
6. Levi B., Brugman S., Wong V.W., Grova M., Longaker M.T., Wan D.C. Palatogenesis: engineering, pathways and pathologies. Organogenesis 2011, 7:242-254.
7. Bhatt S., Diaz R., Trainor P.A. Signals and switches in Mammalian neural crest cell differentiation. Cold Spring Harb. Perspect. Biol. 2013, 5.
8. Kuratani S. Cephalic neural crest cells and the evolution of craniofacial structures in vertebrates: morphological and embryological significance of the premandibular-mandibular boundary. Zoology (Jena) 2005, 108:13-25.
9. Dupin E., Calloni G.W., Le Douarin N.M. The cephalic neural crest of amniote vertebrates is composed of a large majority of precursors endowed with neural, melanocytic, chondrogenic and osteogenic potentialities. Cell Cycle 2010, 9:238-249.
10. Le Douarin N.M., Dieterlen-Lievre F. How studies on the avian embryo have opened new avenues in the understanding of development: a view about the neural and hematopoietic systems. Dev. Growth Differ. 2013, 55:1-14.
11. Stuhlmiller T.J., Garcia-Castro M.I. Current perspectives of the signaling pathways directing neural crest induction. Cell Mol. Life Sci. 2012, 69:3715-3737.
12. Patthey C., Edlund T., Gunhaga L. Wnt-regulated temporal control of BMP exposure directs the choice between neural plate border and epidermal fate. Development 2009, 136:73-83.
13. Patthey C., Gunhaga L. Signaling pathways regulating ectodermal cell fate choices. Exp. Cell Res. 2014, 321(1):11-16. http://dx.doi.org/10.1016/j.yexcr.2013.08.002.
14. Meulemans D., Bronner-Fraser M. Gene-regulatory interactions in neural crest evolution and development. Dev. Cell 2004, 7:291-299.
15. M.S. Simoes-Costa, S.J. McKeown, J. Tan-Cabugao, T. Sauka-Spengler, M.E. Bronner, Dynamic and differential regulation of stem cell factor FoxD3 in the neural crest is encrypted in the genome, PLoS Genet. 8, e1003142.
16. N. de Croze, F. Maczkowiak, A.H. Monsoro-Burq, Reiterative AP2a activity controls sequential steps in the neural crest gene regulatory network, Proc. Natl. Acad. Sci. USA 108 (2011) 155-160.
17. Noden D.M., Trainor P.A. Relations and interactions between cranial mesoderm and neural crest populations. J. Anat. 2005, 207:575-601.
18. Noden D.M. The role of the neural crest in patterning of avian cranial skeletal, connective, and muscle tissues. Dev. Biol. 1983, 96:144-165.
19. Evans D.J., Noden D.M. Spatial relations between avian craniofacial neural crest and paraxial mesoderm cells. Dev. Dyn. 2006, 235:1310-1325.
20. Danielian P.S., Muccino D., Rowitch D.H., Michael S.K., McMahon A.P. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 1998, 8:1323-1326.
21. Lewis A.E., Vasudevan H.N., O'Neill A.K., Soriano P., Bush J.O. The widely used Wnt1-Cre transgene causes developmental phenotypes by ectopic activation of Wnt signaling. Dev. Biol. 2013, 379:229-234.
22. Yamauchi Y., Abe K., Mantani A., Hitoshi Y., Suzuki M., Osuzu F., Kuratani S., Yamamura K. A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice. Dev. Biol. 1999, 212:191-203.
23. Chai Y., Jiang X., Ito Y., Bringas P., Han J., Rowitch D.H., Soriano P., McMahon A.P., Sucov H.M. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development 2000, 127:1671-1679.
24. Jiang X., Iseki S., Maxson R.E., Sucov H.M., Morriss-Kay G.M. Tissue origins and interactions in the mammalian skull vault. Dev. Biol. 2002, 241:106-116.
25. Chai Y., Maxson R.E. Recent advances in craniofacial morphogenesis. Dev. Dyn. 2006, 235:2353-2375.
26. Senarath-Yapa K., Li S., Meyer N.P., Longaker M.T., Quarto N. Integration of multiple signaling pathways determines differences in the osteogenic potential and tissue regeneration of neural crest-derived and mesoderm-derived calvarial bones. Int. J. Mol. Sci. 2013, 14:5978-5997.
27. Li S., Quarto N., Longaker M.T. Activation of FGF signaling mediates proliferative and osteogenic differences between neural crest derived frontal and mesoderm parietal derived bone. PLoS One 2010, 5:e14033.
28. Quarto N., Wan D.C., Kwan M.D., Panetta N.J., Li S., Longaker M.T. Origin matters: differences in embryonic tissue origin and Wnt signaling determine the osteogenic potential and healing capacity of frontal and parietal calvarial bones. J. Bone Miner. Res. 2010, 25:1680-1694.
29. Li S., Meyer N.P., Quarto N., Longaker M.T. Integration of multiple signaling regulates through apoptosis the differential osteogenic potential of neural crest-derived and mesoderm-derived Osteoblasts. PLoS One 2013, 8:e58610.
30. Behr B., Panetta N.J., Longaker M.T., Quarto N. Different endogenous threshold levels of Fibroblast Growth Factor-ligands determine the healing potential of frontal and parietal bones. Bone 2010, 47:281-294.
31. Rice D.P., Rice R., Thesleff I. Molecular mechanisms in calvarial bone and suture development, and their relation to craniosynostosis. Eur. J. Orthod. 2003, 25:139-148.
32. Morriss-Kay G.M., Wilkie A.O. Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies. J. Anat. 2005, 207:637-653.
33. Manzanares M.C., Goret-Nicaise M., Dhem A. Metopic sutural closure in the human skull. J. Anat. 1988, 161:203-215.
34. Warren S.M., Greenwald J.A., Spector J.A., Bouletreau P., Mehrara B.J., Longaker M.T. New developments in cranial suture research. Plast. Reconstr. Surg. 2001, 107:523-540.
35. Sahar D.E., Longaker M.T., Quarto N. Sox9 neural crest determinant gene controls patterning and closure of the posterior frontal cranial suture. Dev. Biol. 2005, 280:344-361.
36. Creuzet S., Schuler B., Couly G., Le Douarin N.M. Reciprocal relationships between Fgf8 and neural crest cells in facial and forebrain development. Proc. Natl. Acad. Sci. USA 2004, 101:4843-4847.
37. Macatee T.L., Hammond B.P., Arenkiel B.R., Francis L., Frank D.U., Moon A.M. Ablation of specific expression domains reveals discrete functions of ectoderm- and endoderm-derived FGF8 during cardiovascular and pharyngeal development. Development 2003, 130:6361-6374.
38. Trumpp A., Depew M.J., Rubenstein J.L., Bishop J.M., Martin G.R. Cre-mediated gene inactivation demonstrates that FGF8 is required for cell survival and patterning of the first branchial arch. Genes Dev. 1999, 13:3136-3148.
39. Szabo-Rogers H.L., Geetha-Loganathan P., Nimmagadda S., Fu K.K., Richman J.M. FGF signals from the nasal pit are necessary for normal facial morphogenesis. Dev. Biol. 2008, 318:289-302.
40. Passos-Bueno M.R., Serti Eacute A.E., Jehee F.S., Fanganiello R., Yeh E. Genetics of craniosynostosis: genes, syndromes, mutations and genotype-phenotype correlations. Front. Oral Biol. 2008, 12:107-143.
41. Wilkie A.O., Morriss-Kay G.M. Genetics of craniofacial development and malformation. Nat. Rev. Genet. 2001, 2:458-468.
42. Anderson J., Burns H.D., Enriquez-Harris P., Wilkie A.O., Heath J.K. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum. Mol. Genet. 1998, 7:1475-1483.
43. Yu K., Herr A.B., Waksman G., Ornitz D.M. Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proc. Natl. Acad. Sci. USA 2000, 97:14536-14541.
44. Ibrahimi O.A., Zhang F., Eliseenkova A.V., Itoh N., Linhardt R.J., Mohammadi M. Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. Hum. Mol. Genet. 2004, 13:2313-2324.
45. Neilson K.M., Friesel R.E. Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J. Biol. Chem. 1995, 270:26037-26040.
46. Mangasarian K., Li Y., Mansukhani A., Basilico C. Mutation associated with Crouzon syndrome causes ligand-independent dimerization and activation of FGF receptor-2. J. Cell. Physiol. 1997, 172:117-125.
47. Tsang M., Dawid I.B. Promotion and attenuation of FGF signaling through the Ras-MAPK pathway. Sci. STKE 2004, 2004:pe17.
48. Shukla V., Coumoul X., Wang R.H., Kim H.S., Deng C.X. RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis. Nat. Genet. 2007, 39:1145-1150.
49. Akita H., Harashima H. Advances in non-viral gene delivery: using multifunctional envelope-type nano-device. Expert Opin. Drug Deliv. 2008, 5:847-859.
50. Kamiya N., Mishina Y. New insights on the roles of BMP signaling in bone-A review of recent mouse genetic studies. Biofactors 2011, 37:75-82.
51. Urist M.R. Bone: formation by autoinduction. Science 1965, 150:893-899.
52. Bandyopadhyay A., Yadav P.S., Prashar P. BMP signaling in development and diseases: a pharmacological perspective. Biochem. Pharmacol. 2013, 85:857-864.
53. Jabs E.W., Muller U., Li X., Ma L., Luo W., Haworth I.S., Klisak I., Sparkes R., Warman M.L., Mulliken J.B., et al. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 1993, 75:443-450.
54. Florisson J.M., Verkerk A.J., Huigh D., Hoogeboom A.J., Swagemakers S., Kremer A., Heijsman D., Lequin M.H., Mathijssen I.M., van der Spek P.J. Boston type craniosynostosis: report of a second mutation in MSX2. Am. J. Med. Genet. A 2013, 161:2626-2633.
55. Janssen A., Hosen M.J., Jeannin P., Coucke P.J., De Paepe A., Vanakker O.M. Second family with the boston-type craniosynostosis syndrome: novel mutation and expansion of the clinical spectrum. Am. J. Med. Genet. A 2013, 161:2352-2357.
56. Liu Y.H., Tang Z., Kundu R.K., Wu L., Luo W., Zhu D., Sangiorgi F., Snead M.L., Maxson R.E. Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans. Dev. Biol. 1999, 205:260-274.
57. Brugger S.M., Merrill A.E., Torres-Vazquez J., Wu N., Ting M.C., Cho J.Y., Dobias S.L., Yi S.E., Lyons K., Bell J.R., Arora K., Warrior R., Maxson R. A phylogenetically conserved cis-regulatory module in the Msx2 promoter is sufficient for BMP-dependent transcription in murine and Drosophila embryos. Development 2004, 131:5153-5165.
58. Sun J., Ishii M., Ting M.C., Maxson R. Foxc1 controls the growth of the murine frontal bone rudiment by direct regulation of a Bmp response threshold of Msx2. Development 2013, 140:1034-1044.
59. Satokata I., Maas R. Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nat. Genet. 1994, 6:348-356.
60. Satokata I., Ma L., Ohshima H., Bei M., Woo I., Nishizawa K., Maeda T., Takano Y., Uchiyama M., Heaney S., Peters H., Tang Z., Maxson R., Maas R. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat. Genet. 2000, 24:391-395.
61. Ishii M., Merrill A.E., Chan Y.S., Gitelman I., Rice D.P., Sucov H.M., Maxson R.E. Msx2 and Twist cooperatively control the development of the neural crest-derived skeletogenic mesenchyme of the murine skull vault. Development 2003, 130:6131-6142.
62. Ishii M., Han J., Yen H.Y., Sucov H.M., Chai Y., Maxson R.E. Combined deficiencies of Msx1 and Msx2 cause impaired patterning and survival of the cranial neural crest. Development 2005, 132:4937-4950.
63. Roybal P.G., Wu N.L., Sun J., Ting M.C., Schafer C.A., Maxson R.E. Inactivation of Msx1 and Msx2 in neural crest reveals an unexpected role in suppressing heterotopic bone formation in the head. Dev. Biol. 2010, 343:28-39.
64. Warren S.M., Brunet L.J., Harland R.M., Economides A.N., Longaker M.T. The BMP antagonist noggin regulates cranial suture fusion. Nature 2003, 422:625-629.
65. Shen K., Krakora S.M., Cunningham M., Singh M., Wang X., Hu F.Z., Post J.C., Ehrlich G.D. Medical treatment of craniosynostosis: recombinant Noggin inhibits coronal suture closure in the rat craniosynostosis model. Orthod. Craniofac. Res. 2009, 12:254-262.
66. Cooper G.M., Curry C., Barbano T.E., Burrows A.M., Vecchione L., Caccamese J.F., Norbutt C.S., Costello B.J., Losee J.E., Moursi A.M., Huard J., Mooney M.P. Noggin inhibits postoperative resynostosis in craniosynostotic rabbits. J. Bone Miner. Res. 2007, 22:1046-1054.
67. Cray J., Burrows A.M., Vecchione L., Caccamese J.F., Losee J.E., Moursi A.M., Siegel M.I., Cooper G.M., Mooney M.P. Blocking bone morphogenetic protein function using in vivo noggin therapy does not rescue premature suture fusion in rabbits with delayed-onset craniosynostosis. Plast. Reconstr. Surg. 2011, 127:1163-1172.
68. Kamiya N., Ye L., Kobayashi T., Mochida Y., Yamauchi M., Kronenberg H.M., Feng J.Q., Mishina Y. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development 2008, 135:3801-3811.
69. Komatsu Y., Yu P.B., Kamiya N., Pan H., Fukuda T., Scott G.J., Ray M.K., Yamamura K., Mishina Y. Augmentation of Smad-dependent BMP signaling in neural crest cells causes craniosynostosis in mice. J. Bone Miner. Res. 2013, 28:1422-1433.
70. Justice C.M., Yagnik G., Kim Y., Peter I., Jabs E.W., Erazo M., Ye X., Ainehsazan E., Shi L., Cunningham M.L., Kimonis V., Roscioli T., Wall S.A., Wilkie A.O., Stoler J., Richtsmeier J.T., Heuze Y., Sanchez-Lara P.A., Buckley M.F., Druschel C.M., Mills J.L., Caggana M., Romitti P.A., Kay D.M., Senders C., Taub P.J., Klein O.D., Boggan J., Zwienenberg-Lee M., Naydenov C., Kim J., Wilson A.F., Boyadjiev S.A. A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat. Genet. 2012, 44:1360-1364.
71. Schoenebeck J.J., Hutchinson S.A., Byers A., Beale H.C., Carrington B., Faden D.L., Rimbault M., Decker B., Kidd J.M., Sood R., Boyko A.R., Fondon J.W., Wayne R.K., Bustamante C.D., Ciruna B., Ostrander E.A. Variation of BMP3 contributes to dog breed skull diversity. PLoS Genet. 2012, 8:e1002849.
72. Dwivedi P.P., Grose R.H., Filmus J., Hii C.S., Xian C.J., Anderson P.J., Powell B.C. Regulation of bone morphogenetic protein signalling and cranial osteogenesis by Gpc1 and Gpc3. Bone 2013, 55:367-376.
73. Kishigami S., Mishina Y. BMP signaling and early embryonic patterning. Cytokine Growth Factor Rev. 2005, 16:265-278.
74. Dudas M., Sridurongrit S., Nagy A., Okazaki K., Kaartinen V. Craniofacial defects in mice lacking BMP type I receptor Alk2 in neural crest cells. Mech. Dev. 2004, 121:173-182.
75. Nomura-Kitabayashi A., Phoon C.K., Kishigami S., Rosenthal J., Yamauchi Y., Abe K., Yamamura K., Samtani R., Lo C.W., Mishina Y. Outflow tract cushions perform a critical valve-like function in the early embryonic heart requiring BMPRIA-mediated signaling in cardiac neural crest. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1617-H1628.
76. Stottmann R.W., Choi M., Mishina Y., Meyers E.N., Klingensmith J. BMP receptor IA is required in mammalian neural crest cells for development of the cardiac outflow tract and ventricular myocardium. Development 2004, 131:2205-2218.
77. Morikawa Y., Zehir A., Maska E., Deng C., Schneider M.D., Mishina Y., Cserjesi P. BMP signaling regulates sympathetic nervous system development through Smad4-dependent and -independent pathways. Development 2009, 136:3575-3584.
78. Lana-Elola E., Tylzanowski P., Takatalo M., Alakurtti K., Veistinen L., Mitsiadis T.A., Graf D., Rice R., Luyten F.P., Rice D.P. Noggin null allele mice exhibit a microform of holoprosencephaly. Hum. Mol. Genet. 2011, 20:4005-4015.
79. Klingensmith J., Matsui M., Yang Y.P., Anderson R.M. Roles of bone morphogenetic protein signaling and its antagonism in holoprosencephaly. Am. J. Med. Genet. C Semin. Med. Genet. 2010, 154C:43-51.
80. Yang Y.P., Anderson R.M., Klingensmith J. BMP antagonism protects Nodal signaling in the gastrula to promote the tissue interactions underlying mammalian forebrain and craniofacial patterning. Hum. Mol. Genet. 2010, 19:3030-3042.
81. Yang Y.P., Klingensmith J. Roles of organizer factors and BMP antagonism in mammalian forebrain establishment. Dev. Biol. 2006, 296:458-475.
82. Brugmann S.A., Goodnough L.H., Gregorieff A., Leucht P., ten Berge D., Fuerer C., Clevers H., Nusse R., Helms J.A. Wnt signaling mediates regional specification in the vertebrate face. Development 2007, 134:3283-3295.
83. Basch M.L., Bronner-Fraser M. Neural crest inducing signals. Adv. Exp. Med. Biol. 2006, 589:24-31.
84. Song L., Li Y., Wang K., Wang Y.Z., Molotkov A., Gao L., Zhao T., Yamagami T., Wang Y., Gan Q., Pleasure D.E., Zhou C.J. Lrp6-mediated canonical Wnt signaling is required for lip formation and fusion. Development 2009, 136:3161-3171.
85. Lan Y., Ryan R.C., Zhang Z., Bullard S.A., Bush J.O., Maltby K.M., Lidral A.C., Jiang R. Expression of Wnt9b and activation of canonical Wnt signaling during midfacial morphogenesis in mice. Dev. Dyn. 2006, 235:1448-1454.
86. Geetha-Loganathan P., Nimmagadda S., Antoni L., Fu K., Whiting C.J., Francis-West P., Richman J.M. Expression of WNT signalling pathway genes during chicken craniofacial development. Dev. Dyn. 2009, 238:1150-1165.
87. Brault V., Moore R., Kutsch S., Ishibashi M., Rowitch D.H., McMahon A.P., Sommer L., Boussadia O., Kemler R. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 2001, 128:1253-1264.
88. Mirando A.J., Maruyama T., Fu J., Yu H.M., Hsu W. Beta-catenin/cyclin D1 mediated development of suture mesenchyme in calvarial morphogenesis. BMC Dev. Biol. 2010, 10:116.
89. Yu H.M., Jerchow B., Sheu T.J., Liu B., Costantini F., Puzas J.E., Birchmeier W., Hsu W. The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development 2005, 132:1995.
90. Liu B., Yu H.M., Hsu W. Craniosynostosis caused by Axin2 deficiency is mediated through distinct functions of beta-catenin in proliferation and differentiation. Dev. Biol. 2007, 301:298-308.
91. Maruyama T., Mirando A.J., Deng C.X., Hsu W. The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development. Sci. Signal. 2010, 3. (ra40).
92. Behr B., Longaker M.T., Quarto N. Absence of endochondral ossification and craniosynostosis in posterior frontal cranial sutures of Axin2(-/-) mice. PLoS One 2013, 8:e70240.
93. Chen Z.F., Behringer R.R. twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev. 1995, 9:686-699.
94. el Ghouzzi V., Le Merrer M., Perrin-Schmitt F., Lajeunie E., Benit P., Renier D., Bourgeois P., Bolcato-Bellemin A.L., Munnich A., Bonaventure J. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat. Genet. 1997, 15:42-46.
95. Howard T.D., Paznekas W.A., Green E.D., Chiang L.C., Ma N., Ortiz de Luna R.I., Garcia Delgado C., Gonzalez-Ramos M., Kline A.D., Jabs E.W. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat. Genet. 1997, 15:36-41.
96. Bourgeois P., Bolcato-Bellemin A.L., Danse J.M., Bloch-Zupan A., Yoshiba K., Stoetzel C., Perrin-Schmitt F. The variable expressivity and incomplete penetrance of the twist-null heterozygous mouse phenotype resemble those of human Saethre-Chotzen syndrome. Hum. Mol. Genet. 1998, 7:945-957.
97. Carver E.A., Oram K.F., Gridley T. Craniosynostosis in Twist heterozygous mice: a model for Saethre-Chotzen syndrome. Anat. Rec. 2002, 268:90-92.
98. Connerney J., Andreeva V., Leshem Y., Mercado M.A., Dowell K., Yang X., Lindner V., Friesel R.E., Spicer D.B. Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure. Dev. Biol. 2008, 318:323-334.
99. Rice D.P., Aberg T., Chan Y., Tang Z., Kettunen P.J., Pakarinen L., Maxson R.E., Thesleff I. Integration of FGF and TWIST in calvarial bone and suture development. Development 2000, 127:1845-1855.
100. Howe L.R., Watanabe O., Leonard J., Brown A.M. Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res. 2003, 63:1906-1913.
101. Behr B., Longaker M.T., Quarto N. Differential activation of canonical Wnt signaling determines cranial sutures fate: a novel mechanism for sagittal suture craniosynostosis. Dev. Biol. 2010, 344:922-940.
102. Behr B., Longaker M.T., Quarto N. Craniosynostosis of coronal suture in twist1 mice occurs through endochondral ossification recapitulating the physiological closure of posterior frontal suture. Front. Physiol. 2011, 2:37.
103. Ahlgren S.C., Bronner-Fraser M. Inhibition of sonic hedgehog signaling in vivo results in craniofacial neural crest cell death. Curr. Biol. 1999, 9:1304-1314.
104. Chiang C., Litingtung Y., Lee E., Young K.E., Corden J.L., Westphal H., Beachy P.A. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 1996, 383:407-413.
105. Jeong J., Mao J., Tenzen T., Kottmann A.H., McMahon A.P. Hedgehog signaling in the neural crest cells regulates the patterning and growth of facial primordia. Genes Dev. 2004, 18:937-951.
106. Belloni E., Muenke M., Roessler E., Traverso G., Siegel-Bartelt J., Frumkin A., Mitchell H.F., Donis-Keller H., Helms C., Hing A.V., Heng H.H., Koop B., Martindale D., Rommens J.M., Tsui L.C., Scherer S.W. Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat. Genet. 1996, 14:353-356.
107. Roessler E., Belloni E., Gaudenz K., Jay P., Berta P., Scherer S.W., Tsui L.C., Muenke M. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat. Genet. 1996, 14:357-360.
108. Solomon B.D., Bear K.A., Wyllie A., Keaton A.A., Dubourg C., David V., Mercier S., Odent S., Hehr U., Paulussen A., Clegg N.J., Delgado M.R., Bale S.J., Lacbawan F., Ardinger H.H., Aylsworth A.S., Bhengu N.L., Braddock S., Brookhyser K., Burton B., Gaspar H., Grix A., Horovitz D., Kanetzke E., Kayserili H., Lev D., Nikkel S.M., Norton M., Roberts R., Saal H., Schaefer G.B., Schneider A., Smith E.K., Sowry E., Spence M.A., Shalev S.A., Steiner C.E., Thompson E.M., Winder T.L., Balog J.Z., Hadley D.W., Zhou N., Pineda-Alvarez D.E., Roessler E., Muenke M. Genotypic and phenotypic analysis of 396 individuals with mutations in Sonic Hedgehog. J. Med. Genet. 2012, 49:473-479.
109. Brugmann S.A., Allen N.C., James A.W., Mekonnen Z., Madan E., Helms J.A. A primary cilia-dependent etiology for midline facial disorders. Hum. Mol. Genet. 2010, 19:1577-1592.
110. Balk K., Biesecker L.G. The clinical atlas of Greig cephalopolysyndactyly syndrome. Am. J. Med. Genet. A 2008, 146A:548-557.
111. Hu D., Helms J.A. The role of sonic hedgehog in normal and abnormal craniofacial morphogenesis. Development 1999, 126:4873-4884.
112. Costa M.A., Borzabadi-Farahani A., Lara-Sanchez P.A., Schweitzer D., Jacobson L., Clarke N., Hammoudeh J., Urata M.M., Magee W.P. Partial craniofacial duplication: a review of the literature and case report. J. Craniomaxillofac. Surg. 2013.
113. Suryawanshi P., Deshpande M., Verma N., Mahendrakar V., Mahendrakar S. Craniofacial duplication: a case report. J. Clin. Diagn. Res. 2013, 7:2025-2026.
114. Eggenschwiler J.T., Anderson K.V. Cilia and developmental signaling. Annu. Rev. Cell Dev. Biol. 2007, 23:345-373.
115. Huangfu D., Liu A., Rakeman A.S., Murcia N.S., Niswander L., Anderson K.V. Hedgehog signalling in the mouse requires intraflagellar transport proteins. Nature 2003, 426:83-87.
116. May S.R., Ashique A.M., Karlen M., Wang B., Shen Y., Zarbalis K., Reiter J., Ericson J., Peterson A.S. Loss of the retrograde motor for IFT disrupts localization of Smo to cilia and prevents the expression of both activator and repressor functions of Gli. Dev. Biol. 2005, 287:378-389.
117. Corbit K.C., Aanstad P., Singla V., Norman A.R., Stainier D.Y., Reiter J.F. Vertebrate smoothened functions at the primary cilium. Nature 2005, 437:1018-1021.
118. Goetz S.C., Anderson K.V. The primary cilium: a signalling centre during vertebrate development. Nat. Rev. Genet. 2010, 11:331-344.
119. Nozawa Y.I., Lin C., Chuang P.T. Hedgehog signaling from the primary cilium to the nucleus: an emerging picture of ciliary localization, trafficking and transduction. Curr. Opin. Genet. Dev. 2013, 23:429-437.
120. Kondo S., Sato-Yoshitake R., Noda Y., Aizawa H., Nakata T., Matsuura Y., Hirokawa N. KIF3A is a new microtubule-based anterograde motor in the nerve axon. J. Cell Biol. 1994, 125:1095-1107.
121. Spassky N., Han Y.G., Aguilar A., Strehl L., Besse L., Laclef C., Ros M.R., Garcia-Verdugo J.M., Alvarez-Buylla A. Primary cilia are required for cerebellar development and Shh-dependent expansion of progenitor pool. Dev. Biol. 2008, 317:246-259.
122. Kolpakova-Hart E., Jinnin M., Hou B., Fukai N., Olsen B.R. Kinesin-2 controls development and patterning of the vertebrate skeleton by Hedgehog- and Gli3-dependent mechanisms. Dev. Biol. 2007, 309:273-284.
123. Zaghloul N.A., Brugmann S.A. The emerging face of primary cilia. Genesis 2011, 49:231-246.
124. Brugmann S.A., Cordero D.R., Helms J.A. Craniofacial ciliopathies: a new classification for craniofacial disorders. Am. J. Med. Genet. A 2010, 152A:2995-3006.
125. Neugebauer J.M., Amack J.D., Peterson A.G., Bisgrove B.W., Yost H.J. FGF signalling during embryo development regulates cilia length in diverse epithelia. Nature 2009, 458:651-654.
126. Komatsu Y., Kaartinen V., Mishina Y. Cell cycle arrest in node cells governs ciliogenesis at the node to break left-right symmetry. Development 2011, 138:3915-3920.
127. Zhang Z., Wlodarczyk B.J., Niederreither K., Venugopalan S., Florez S., Finnell R.H., Amendt B.A. Fuz regulates craniofacial development through tissue specific responses to signaling factors. PLoS One 2011, 6:e24608.
128. Tabler J.M., Barrell W.B., Szabo-Rogers H.L., Healy C., Yeung Y., Perdiguero E.G., Schulz C., Yannakoudakis B.Z., Mesbahi A., Wlodarczyk B., Geissmann F., Finnell R.H., Wallingford J.B., Liu K.J. Fuz mutant mice reveal shared mechanisms between ciliopathies and FGF-related syndromes. Dev. Cell 2013, 25:623-635.
129. Clarke A.J., Cooper D.N., Krawczak M., Tyler-Smith C., Wallace H.M., Wilkie A.O., Raymond F.L., Chadwick R., Craddock N., John R., Gallacher J., Chiano M. 'Sifting the significance from the data' - the impact of high-throughput genomic technologies on human genetics and health care. Hum. Genomics 2012, 6:11.
130. Twigg S.R., Vorgia E., McGowan S.J., Peraki I., Fenwick A.L., Sharma V.P., Allegra M., Zaragkoulias A., Sadighi Akha E., Knight S.J., Lord H., Lester T., Izatt L., Lampe A.K., Mohammed S.N., Stewart F.J., Verloes A., Wilson L.C., Healy C., Sharpe P.T., Hammond P., Hughes J., Taylor S., Johnson D., Wall S.A., Mavrothalassitis G., Wilkie A.O. Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis. Nat. Genet. 2013, 45:308-313.
131. Sharma V.P., Fenwick A.L., Brockop M.S., McGowan S.J., Goos J.A., Hoogeboom A.J., Brady A.F., Jeelani N.O., Lynch S.A., Mulliken J.B., Murray D.J., Phipps J.M., Sweeney E., Tomkins S.E., Wilson L.C., Bennett S., Cornall R.J., Broxholme J., Kanapin A., Johnson D., Wall S.A., van der Spek P.J., Mathijssen I.M., Maxson R.E., Twigg S.R., Wilkie A.O. Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis. Nat. Genet. 2013, 45:304-307.
132. Daluiski A., Engstrand T., Bahamonde M.E., Gamer L.W., Agius E., Stevenson S.L., Cox K., Rosen V., Lyons K.M. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat. Genet. 2001, 27:84-88.
133. Attanasio C., Nord A.S., Zhu Y., Blow M.J., Li Z., Liberton D.K., Morrison H., Plajzer-Frick I., Holt A., Hosseini R., Phouanenavong S., Akiyama J.A., Shoukry M., Afzal V., Rubin E.M., FitzPatrick D.R., Ren B., Hallgrimsson B., Pennacchio L.A., Visel A. Fine tuning of craniofacial morphology by distant-acting enhancers. Science 2013, 342:1241006.
134. Wang S.K., Komatsu Y., Mishina Y. Potential contribution of neural crest cells to dental enamel formation. Biochem. Biophys. Res. Commun. 2011, 415:114-119.
135. Liu H.X., Komatsu Y., Mishina Y., Mistretta C.M. Neural crest contribution to lingual mesenchyme, epithelium and developing taste papillae and taste buds. Dev. Biol. 2012, 368:294-303.
136. Ishii M., Arias A.C., Liu L., Chen Y.B., Bronner M.E., Maxson R.E. A stable cranial neural crest cell line from mouse. Stem Cells Dev. 2012, 21:3069-3080.
137. Zhang X., Xie C., Lin A.S., Ito H., Awad H., Lieberman J.R., Rubery P.T., Schwarz E.M., O'Keefe R.J., Guldberg R.E. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J. Bone Miner. Res. 2005, 20:2124-2137.
138. Colnot C. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J. Bone Miner. Res. 2009, 24:274-282.
139. Chappuis V., Gamer L., Cox K., Lowery J.W., Bosshardt D.D., Rosen V. Periosteal BMP2 activity drives bone graft healing. Bone 2011, 51:800-809.